These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7792389)

  • 1. Effects of a single drip infusion of lipo-prostaglandin E1 on vibratory threshold in patients with diabetic neuropathy.
    Tawata M; Nitta K; Kurihara A; Nagasaka T; Iwase E; Gan N; Inoue M; Onaya T
    Prostaglandins; 1995 Jan; 49(1):27-39. PubMed ID: 7792389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prostaglandin E1.alpha CD on vibratory threshold determined with the SMV-5 vibrometer in patients with diabetic neuropathy.
    Shindo H; Tawata M; Inoue M; Yokomori N; Hosaka Y; Ohtaka M; Onaya T
    Diabetes Res Clin Pract; 1994 Jul; 24(3):173-80. PubMed ID: 7988349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
    Hong L; Zhang J; Shen J
    J Diabetes Complications; 2015; 29(8):1283-6. PubMed ID: 26355026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes.
    Wu JD; Tao S; Jin X; Jiang LL; Shen Y; Luo Y; Zhang P; Lee KO; Ye L; Ma JH
    Prostaglandins Other Lipid Mediat; 2016 Nov; 126():24-28. PubMed ID: 27421690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Effect of Pancreatic Kininogenase on Treatment of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes.
    Jin YP; Su XF; Li HQ; Wu JD; Ding B; Sun R; Shan T; Ye L; Ma JH
    Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):618-621. PubMed ID: 27701714
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echography.
    Okuda Y; Mizutani M; Ogawa M; Sone H; Asano M; Tsurushima Y; Morishima Y; Asakura Y; Suzuki S; Isaka M
    Diabetes Res; 1993; 22(2):87-95. PubMed ID: 8205741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors.
    Itoh Y; Yasui T; Kakizawa H; Makino M; Fujiwara K; Kato T; Imamura S; Yamamoto K; Hishida H; Nakai A; Itoh M; Nagasaka A
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):221-34. PubMed ID: 11577785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy.
    Tawata M; Kurihara A; Nitta K; Iwase E; Gan N; Onaya T
    Diabetes Res Clin Pract; 1994 Dec; 26(2):121-8. PubMed ID: 7705193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
    Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in blood flow and diabetic neuropathy by thromboxane A2 dual blocker KDI-792.
    Ono Y; Katoh M; Hirayama A; Koike T
    Prostaglandins Leukot Essent Fatty Acids; 1995 Aug; 53(2):139-45. PubMed ID: 7480076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy.
    Hotta N; Sugimura K; Tsuchida I; Sano T; Koh N; Matsumae H; Sakamoto N
    Clin Ther; 1994; 16(6):1007-15. PubMed ID: 7697680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments.
    Shun CT; Chang YC; Wu HP; Hsieh SC; Lin WM; Lin YH; Tai TY; Hsieh ST
    Brain; 2004 Jul; 127(Pt 7):1593-605. PubMed ID: 15128619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy.
    Nasseri K; Strijers RL; Dekhuijzen LS; Buster M; Bertelsmann FW
    Electromyogr Clin Neurophysiol; 1998; 38(5):295-9. PubMed ID: 9741007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes.
    Ahn JH; Kim TY; Kim YJ; Han MW; Yoon TH; Chung JW
    Diabet Med; 2006 Dec; 23(12):1339-43. PubMed ID: 17116185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
    Chino Y; Minagawa T; Kohno Y; Fukushima K; Momma K
    Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.
    Gelber DA; Pfeifer MA; Broadstone VL; Munster EW; Peterson M; Arezzo JC; Shamoon H; Zeidler A; Clements R; Greene DA
    J Diabetes Complications; 1995; 9(3):170-6. PubMed ID: 7548981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation of combined therapeutic effect of prostaglandin E1 and mecobalamin on diabetic peripheral neuropathy].
    Zhu XP; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):343-4. PubMed ID: 12536730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.